3 completed, 1 terminated, 1 unknown. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Terminated 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow ZymoGenetics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection PEG-rIL-29, Peginterferon alfa-2a, Ribavirin - Hepatitis C, Chronic | Phase 2 | Unknown | ZymoGenetics | 600 | 2010-05-01 | 2011-12-05 |
| Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma recombinant human interleukin-21, immunohistochemistry staining method, laboratory biomarker analysis - Melanoma (Skin) | Phase 2 | Completed | NCIC Clinical Trials Group | 40 | 2007-12-13 | 2023-08-04 |
| The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis Atacicept, Mycophenolate mofetil, Placebo - Lupus Nephritis | Phase 2 / Phase 3 | Terminated | EMD Serono | 6 | 2007-12-01 | 2016-03-23 |
| Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell Carcinoma rIL-21 only, rIL-21 + sorafenib - Carcinoma, Renal Cell | Phase 1 / Phase 2 | Completed | ZymoGenetics | 52 | 2006-10-01 | 2009-05-27 |
| Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting rThrombin - Surgical Hemostasis | Phase 2 | Completed | ZymoGenetics | 72 | 2006-08-01 | 2009-03-09 |
Carcinoma, Renal Cell (1) · Hepatitis C (1) · Hepatitis C, Chronic (1) · Infections (1) · Liver Diseases (1) · Lupus Nephritis (1) · Melanoma (1) · Nephritis (1) · Virus Diseases (1)
Adrenal Cortex Hormones (1) · Immunohistochemistry (1) · Mycophenolic Acid (1) · Ribavirin (1) · Sorafenib (1) · TACI receptor-IgG Fc fragment fusion protein (1) · peginterferon alfa-2a (1) · peginterferon lambda-1a (1) · recombinant human thrombin (1)
United States (4) · Canada (2) · Australia (1) · Austria (1) · Czechia (1) · France (1) · Germany (1) · Italy (1) · Malaysia (1) · Poland (1) · Puerto Rico (1) · Romania (1) · Singapore (1) · Spain (1) · Taiwan (1)
Allan Alexander, MD (1) · Jan Hillson, MD (1) · Naomi Hunder, MD (1) · Teresa M. Petrella (1)
PMID 22325903, PMID 22915661, PMID 24829759, PMID 25042797, PMID 25043197
2009 (1)